Introduction Respiratory syncytial virus (RSV) is an important cause of severe respiratory
illness in older adults and adults with respiratory or cardiovascular comorbidities. Published …

Objective Respiratory syncytial virus (RSV) is a common respiratory pathogen not only in
children, but also in adults. In view of a recent authorization of adult RSV vaccines in Italy …

Background With the licensure of maternal respiratory syncytial virus (RSV) vaccines in
Europe and the United States, data are needed to better characterize the burden of RSV …

Introduction The immune mechanisms supporting partial protection from reinfection and
disease by the respiratory syncytial virus (RSV) have not been fully characterized. In older …

Soon after the discovery that respiratory syncytial virus (RSV) was the major cause of
bronchiolitis in infants, in 1956 [1], vaccines were developed to try and prevent both infection …

Sporadically and periodically, influenza outbreaks threaten global health and the economy.
Antigen drift-induced influenza virus mutations hamper antiviral drug development. Thus, a …

Background Syndromic surveillance often relies on patients presenting to healthcare.
Community cohorts, although more challenging to recruit, could provide additional …

The advent of influenza A (H1N1) drug-resistant strains led to the search quest for more
potent inhibitors of the influenza A virus, especially in this devastating COVID-19 pandemic …

RSV is one of the major infectious agents in paediatrics, and its relationship with air pollution
is frequently observed. However, the molecular basis of this interaction is sparsely reported …

Due to the emergence of drug-resistant strains of influenza A virus (IAV) in recent times, the
need to search and discover more potent anti-IAV inhibitors is of great interest, especially …